JSM Preliminary Online Program
This is the preliminary program for the 2006 Joint Statistical Meetings in Seattle, Washington.

The views expressed here are those of the individual authors
and not necessarily those of the ASA or its board, officers, or staff.


Back to main JSM 2006 Program page




Legend: = Applied Session, = Theme Session, = Presenter, Sheraton Seattle Hotel & Towers = “S”
Washington State Convention & Trade Center = “CC”, Grand Hyatt Seattle = “H”

Add To My Program
430 Wed, 8/9/06, 12:30 PM - 1:50 PM CC-4C-2
Biopharmaceutical Section Roundtables with Lunch (fee event) - Roundtable Lnch
Biopharmaceutical Section, Section on Statistical Consulting, Section on Statistical Graphics
Organizer(s): Amit Bhattacharyya, GlaxoSmithKIine
WL09: Procedures for Controlling the False Discovery Rate in the Multiple Comparison Problems Involving Multiple Endpoint Tests in Clinical TrialsArunava Chakravartty, University of California, Riverside
WL10: Bayesian Approaches to Clinical TrialsDinesh Kumar, Eisai Medical Research
WL11: CANCELLED - How Can Statisticians Better Contribute to Clinical Trials and Intervention Studies in Developing Countries?Craig Borkowf, Centers for Disease Control and Prevention
WL12: Use of Propensity Scoring in Clinical TrialsDaniel P. Reyner, Zimmer, Inc.
WL13: Increasing the Usage of Data from Cross-Over StudiesYonghua Wang, Bristol-Myers Squibb Company
WL14: Statistical Methods for Optimization of Development of Combination ProductsTimothy Montague, GlaxoSmithKline
WL15: How To Explain Complex Statistical Methods to Life ScientistsVadim Kutsyy, Cytokinetics, Inc.
WL16: R-Based Data Analysis and Graphics Applications for Scientists: Moving beyond ExcelBert Gunter, Genentech, Inc.
WL17: Translational Medicine: from R to D and from D to RChi-Hse Teng, Pfizer Inc.; Patricia English, Pfizer Inc.
WL18: Proof of Concept StudiesRobert Smith, Bristol-Myers Squibb Company
WL19: Sensitivity Analysis for Missing Data in Clinical TrialsJie Zhang, Novartis Pharmaceuticals Corporation
WL20: Analysis of Cell-Based, High-Content Imaging DataShuguang Huang, Eli Lilly and Company
WL21: Interval Censored Time-to-Event Data: Examples, Analyses, and AssumptionsDaohai Yu, Duke University
 

JSM 2006 For information, contact jsm@amstat.org or phone (888) 231-3473. If you have questions about the Continuing Education program, please contact the Education Department.
Revised April, 2006